patent number 6534526
The present invention generally relates to various methods for treating the laminitis syndrome in animals. These benefits are obtained by administering to the animals a composition containing an .alpha.-adrenergic antagonist that does not substantially cross the blood brain barrier. In one embodiment, the .alpha.-adrenergic antagonist is domperidone. The domperidone can be administered to the animal either orally, subcutaneously, or intramuscularly and can be used to treat animals suffering from symptoms of laminitis.
Clemson University (Clemson, SC)